{ "cik": 1818093, "cik_padded": "0001818093", "entityName": "SkinHealth Systems Inc.", "fiscal_years": [ { "accn": "0001628280-26-017376", "filed": "2026-03-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 303000.0, "cost_of_revenue": 104426000.0, "eps_diluted": -0.16, "free_cash_flow": 37182000.0, "gross_profit": 196364000.0, "net_income": -9519000.0, "operating_cash_flow": 37485000.0, "operating_income": -20803000.0, "revenue": 300790000.0, "stockholders_equity": 61056000.0, "total_assets": 499803000.0, "total_liabilities": 438747000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6528275541075169, "leverage": 7.1859768081761, "net_margin": -0.0316466637853652, "operating_margin": -0.06916120881678248, "revenue_growth_yoy": -0.10022315686192393, "roa_avg2y": -0.016059236465044716, "roa_period_end": -0.019045503928547848, "roe_avg2y": -0.16868836335604603, "roe_period_end": -0.1559060534591195 } }, { "accn": "0001628280-26-017376", "filed": "2026-03-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 756000.0, "cost_of_revenue": 151998000.0, "eps_diluted": -0.36, "free_cash_flow": 15378000.0, "gross_profit": 182296000.0, "net_income": -29098000.0, "operating_cash_flow": 16134000.0, "operating_income": -67774000.0, "revenue": 334294000.0, "stockholders_equity": 51803000.0, "total_assets": 685683000.0, "total_liabilities": 633880000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5453163981405589, "leverage": 12.23635696774318, "net_margin": -0.0870431416657194, "operating_margin": -0.20273770992001056, "revenue_growth_yoy": -0.16004633270601595, "roa_avg2y": -0.03603922724604222, "roa_period_end": -0.0424365194995355, "roe_avg2y": -0.5233782702148516, "roe_period_end": -0.5617049205644461 } }, { "accn": "0001628280-26-017376", "filed": "2026-03-12", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 30155000.0, "capex": 3825000.0, "cost_of_revenue": 242878000.0, "eps_diluted": -0.76, "free_cash_flow": 17925000.0, "gross_profit": 155113000.0, "net_income": -100116000.0, "operating_cash_flow": 21750000.0, "operating_income": -130917000.0, "revenue": 397991000.0, "stockholders_equity": 59390000.0, "total_assets": 929113000.0, "total_liabilities": 869723000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.38973996899427377, "leverage": 14.644266711567605, "net_margin": -0.2515534270875472, "operating_margin": -0.3289446243759281, "revenue_growth_yoy": 0.08777563983426079, "roa_avg2y": -0.10362923844164877, "roa_period_end": -0.10775438509632305, "roe_avg2y": -0.88424901630874, "roe_period_end": -1.6857383397878432 } }, { "accn": "0001628280-26-017376", "filed": "2026-03-12", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 160000000.0, "capex": 10847000.0, "cost_of_revenue": 117097000.0, "eps_diluted": -0.23, "free_cash_flow": -117447000.0, "gross_profit": 248779000.0, "net_income": 44224000.0, "operating_cash_flow": -106600000.0, "operating_income": -25841000.0, "revenue": 365876000.0, "stockholders_equity": 167053000.0, "total_assets": 1003083000.0, "total_liabilities": 836030000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6799544107839814, "leverage": 5.004579384985603, "net_margin": 0.12087155211055112, "operating_margin": -0.07062775366517618, "revenue_growth_yoy": 0.4067500749752005, "roa_avg2y": 0.03980756914499329, "roa_period_end": 0.044088076460272976, "roe_avg2y": 0.19017517152704763, "roe_period_end": 0.2647303550370242 } }, { "accn": "0001818093-23-000006", "filed": "2025-03-12", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 11201000.0, "cost_of_revenue": 81548000.0, "eps_diluted": -3.71, "free_cash_flow": -39562000.0, "gross_profit": 178538000.0, "net_income": -378764000.0, "operating_cash_flow": -28361000.0, "operating_income": -39928000.0, "revenue": 260086000.0, "stockholders_equity": 298034000.0, "total_assets": 1218806000.0, "total_liabilities": 916509000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6864575563467469, "leverage": 3.0751826972761496, "net_margin": -1.4563029151895912, "operating_margin": -0.15351845158908975, "revenue_growth_yoy": 1.1839082390084976, "roa_avg2y": -0.5254623030282851, "roa_period_end": -0.31076643862928144, "roe_avg2y": -2.8322297704015824, "roe_period_end": -1.2708751350517056 } }, { "accn": "0001628280-24-010638", "filed": "2024-03-12", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 154000.0, "capex": 3501000.0, "cost_of_revenue": 51893000.0, "eps_diluted": -0.85, "free_cash_flow": -15937000.0, "gross_profit": 67199000.0, "net_income": -29175000.0, "operating_cash_flow": -12436000.0, "operating_income": -17182000.0, "revenue": 119092000.0, "stockholders_equity": -30567000.0, "total_assets": 222835000.0, "total_liabilities": 252795000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.5642612434084573, "net_margin": -0.24497867195109663, "operating_margin": -0.1442750142746784, "revenue_growth_yoy": -0.2852607383134381, "roa_period_end": -0.13092647025826284, "roe_avg2y": 1.836349331235248 } }, { "accn": "0001818093-23-000006", "filed": "2023-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 8774000.0, "cost_of_revenue": 60111000.0, "eps_diluted": -0.05, "free_cash_flow": -7046000.0, "gross_profit": 106512000.0, "net_income": -1638000.0, "operating_cash_flow": 1728000.0, "operating_income": 13462000.0, "revenue": 166623000.0, "stockholders_equity": -1208000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.6392394807439549, "net_margin": -0.009830575610810032, "operating_margin": 0.0807931678099662, "roe_avg2y": 3.5842450765864333 } }, { "accn": "0001818093-22-000046", "filed": "2022-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": 294000.0 }, "period_end": "2018-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001628280-26-017376", "filed": "2026-03-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001818093.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001818093.json" }, "ticker": "SKIN" }